Astrana Health (ASTH) vs Insperity (NSP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Astrana Health (ASTH) has outperformed Insperity (NSP) over the past year, gaining 22.5% versus a loss of 0.5%. Over five years, ASTH leads with a -48.0% price change compared with -59.1% for NSP. Astrana Health is the larger company by market cap ($1.84 billion vs $1.84 billion), about 1.0 times the size.
On valuation, Astrana Health trades at a lower forward P/E (10.2x vs 17.9x for Insperity). Insperity pays a dividend yielding 4.98%, while Astrana Health does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTH | NSP |
|---|---|---|
| Share price | $37.14 | $48.23 |
| Market cap | $1.84B | $1.84B |
| 1-day change | +0.38% | +3.90% |
| YTD return | +49.70% | +24.56% |
| 1-year return | +22.45% | -0.50% |
| 5-year return | -48.05% | -59.11% |
| P/E ratio (TTM) | 44.75 | — |
| Forward P/E | 10.21 | 17.88 |
| EPS (TTM) | $0.83 | $-0.44 |
| Dividend yield | 0.00% | 4.98% |
| Annual dividend | $0.00 | $2.40 |
| 52-week high | $51.60 | $55.90 |
| 52-week low | $18.08 | $18.57 |
| Distance from 52-week high | -28.02% | -13.72% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +39.12% | +7.30% |
| Average volume | 459.44K | 505.43K |
| Shares outstanding | 49.60M | 38.20M |
| Employees | 3,000 | 304,407 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Professional Services | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ASTH has outperformed NSP by 22.9 percentage points over the past year.
- Insperity offers a meaningfully higher dividend yield (4.98% vs 0.00%).
About Astrana Health
ASTH stock →Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Consumer Discretionary · Professional Services · 3,000 employees
About Insperity
NSP stock →Insperity, Inc. engages in the provision of human resources (HR) and business solutions to improve business performance for small and medium-sized businesses primarily in the United States.
Consumer Discretionary · Professional Services · 304,407 employees
ASTH vs NSP FAQ
Which is bigger, Astrana Health or Insperity?
Astrana Health (ASTH) is larger, with a market capitalization of $1.84B compared with $1.84B for Insperity (NSP).
Which stock has performed better over the past year, ASTH or NSP?
ASTH returned +22.45% over the past 12 months, compared with -0.50% for NSP (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Astrana Health or Insperity?
Insperity pays a dividend yielding 4.98%, while Astrana Health does not currently pay a regular dividend.
Are Astrana Health and Insperity in the same industry?
Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.